Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Obtaining cystatin-C levels useful in chronic kidney disease
- Author:
- Doug Brunk
SAN FRANCISCO – New approaches to estimating glomerular filtration rates offer potentially better, and more useful, results.
News
Targeted therapy may be possible for pityriasis rubra pilaris
- Author:
- Doug Brunk
CHICAGO – The discovery of the CARD14 mutation as the cause of the familial variant “brings us closer to an understanding of juvenile PRP,” and to...
News
Study findings support uncapping MELD score
- Author:
- Doug Brunk
Uncapping the current Model for End-Stage Liver Disease (MELD) score may provide a better path toward making sure that patients most in need of a...
News
Radiofrequency devices appear to reduce vaginal laxity
- Author:
- Doug Brunk
Radiofrequency energy-based devices are emerging as options for vaginal rejuvenation.
News
Maintenance therapy typically required after laser hair removal
- Author:
- Doug Brunk
The best candidates for laser hair removal are patients who have a light skin color and dark hair, and those who have thick, coarse hair.
News
How to tackle telangiectasias with light
- Author:
- Doug Brunk
When treating telangiectasias with light-based devices, desired endpoints and settings are among the factors to consider, according to Dr. Kristen...
News
Tips for avoiding laser treatment complications
- Author:
- Doug Brunk
SAN DIEGO – Avoiding a cookbook approach when using lasers will help avoid complications, according to Mathew M. Avram, MD, JD.
News
Reduced starting dose of sorafenib for HCC appears safe
- Author:
- Doug Brunk
The initiation of sorafenib at a reduced dosage may be a safe and reasonable strategy for some patients with hepatocellular carcinoma.
News
Does microneedling have a role in aesthetics?
- Author:
- Doug Brunk
SAN DIEGO – Although questions that include optimal treatment intervals and mechanism of action remain, Jill S. Waibel, MD, believes microneedle...
News
Light alcohol use did not affect liver fibrosis progression in HIV/HCV-coinfected women
- Author:
- Doug Brunk
Women coinfected with HIV and HCV who drank light and moderate amounts of alcohol did not experience significant progression of liver fibrosis.
News
Waging war against medical misinformation
- Author:
- Doug Brunk
Dr. Gunter uses social media to dispel claims about modern-day “snake oil.”
News
Study reveals limits of 4-D CT scanning for parathyroid disease
- Author:
- Doug Brunk
Four-dimensional computed tomography can miss some types of parathyroid disease.
News
Expert shares tips for spotting allergic contact dermatitis in children
- Author:
- Doug Brunk
CHICAGO – Allergic contact dermatitis could be the culprit when severe eczema persists in a pediatric patient despite your best treatment efforts...
News
Study shows more changes, less stopping of PsA systemic drugs
- Author:
- Doug Brunk
Between 2004 and 2015, about 43% of PsA patients were treated with a biologic agent, results from a large study of national claims data showed.
News
Five-year outcomes favor on- versus off-pump CABG
- Author:
- Doug Brunk
“It’s time to change the discussion and choose the procedure that is best for the patient.”